BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8608659)

  • 21. Persistence of beta 2-microglobulin amyloid 10 years after renal transplantation.
    Kessler M; Aymard B; Pourel J
    Nephrol Dial Transplant; 1994; 9(3):333-4. PubMed ID: 8052450
    [No Abstract]   [Full Text] [Related]  

  • 22. The effect of hollow-fiber dialyzer Plivadial Altra-Flux 140 on beta-2-microglobulin removal.
    Kes P; Zubcić A; Ratković-Gusić I; Prsa M; Sefer S
    Acta Med Croatica; 1997; 51(2):105-9. PubMed ID: 9204596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cutaneous and lingual papules as a sign of beta 2 microglobulin-derived amyloidosis in a long-term hemodialysis patient.
    Uenotsuchi T; Imafuku S; Nagata M; Kiryu H; Morita K; Koga T; Furue M
    Eur J Dermatol; 2003; 13(4):393-5. PubMed ID: 12948922
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beta 2-microglobulin modified with advanced glycation end products modulates collagen synthesis by human fibroblasts.
    Owen WF; Hou FF; Stuart RO; Kay J; Boyce J; Chertow GM; Schmidt AM
    Kidney Int; 1998 May; 53(5):1365-73. PubMed ID: 9573554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beta2-microglobulin amyloidosis in hemodialysis and peritoneal dialysis patients.
    Dervisoglu E; Anik Y; Erdogan S; Akansel G; Yilmaz A
    Ther Apher Dial; 2008 Aug; 12(4):306-10. PubMed ID: 18789118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amyloidosis and its impact on patients with ESRD.
    Copeland SD
    Nephrol Nurs J; 2006; 33(1):31-3; quiz 34-5. PubMed ID: 16538926
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Scintigraphic methods to detect beta2-microglobulin associated amyloidosis (Abeta2-microglobulin amyloidosis).
    Floege J; Schäffer J; Koch KM
    Nephrol Dial Transplant; 2001; 16 Suppl 4():12-6. PubMed ID: 11402091
    [TBL] [Abstract][Full Text] [Related]  

  • 28. beta 2-microglobulin and amyloidosis: who is at risk?
    Davison AM
    Nephrol Dial Transplant; 1995; 10 Suppl 10():48-51. PubMed ID: 8825433
    [No Abstract]   [Full Text] [Related]  

  • 29. Interaction between beta 2-microglobulin and advanced glycation end products in the development of dialysis related-amyloidosis.
    Hou FF; Chertow GM; Kay J; Boyce J; Lazarus JM; Braatz JA; Owen WF
    Kidney Int; 1997 May; 51(5):1514-9. PubMed ID: 9150467
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beta-2-microglobulin is superior to N-acetyl-beta-glucosaminidase in predicting prognosis in idiopathic membranous nephropathy.
    Hofstra JM; Deegens JK; Willems HL; Wetzels JF
    Nephrol Dial Transplant; 2008 Aug; 23(8):2546-51. PubMed ID: 18308774
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A case report of severe visceral beta2-microglobulin-derived amyloidosis without obvious joint symptoms or radiological findings in a chronic hemodialyzed patient with systemic lupus erythematosus.
    Koda R; Yamazaki H; Kazama J; Ito T; Saeki T; Emura I; Miyamura S; Narita I; Gejyo F
    Ther Apher Dial; 2009 Jun; 13(3):232-7. PubMed ID: 19527472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Beta 2-microglobulin in medical disease].
    Hansen PB; Olsen NV
    Ugeskr Laeger; 1989 Nov; 151(45):2960-2. PubMed ID: 2686143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cervical discs are most susceptible to beta 2-microglobulin amyloid deposition in the vertebral column.
    Ohashi K; Hara M; Kawai R; Ogura Y; Honda K; Nihei H; Mimura N
    Kidney Int; 1992 Jun; 41(6):1646-52. PubMed ID: 1501421
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Amyloidosis and renal failure].
    Musini S; Savazzi GM
    Recenti Prog Med; 1999 Oct; 90(10):530-5. PubMed ID: 10592739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beta 2-microglobulin amyloidosis.
    Saito A
    Nephrol Dial Transplant; 1994; 9 Suppl 2():116-9. PubMed ID: 8065602
    [No Abstract]   [Full Text] [Related]  

  • 36. Diagnostic approaches to AB-amyloidosis.
    Floege J
    Blood Purif; 1991; 9(2):63-9. PubMed ID: 1760143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dialysis-associated amyloidosis.
    Drüeke T; Touam M; Zingraff J
    Adv Ren Replace Ther; 1995 Jan; 2(1):24-39. PubMed ID: 7614334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prevention of dialysis-related amyloidosis].
    Yamamoto S; Gejyo F; Kazama JJ
    Nihon Rinsho; 2004 Jun; 62 Suppl 6():353-6. PubMed ID: 15250323
    [No Abstract]   [Full Text] [Related]  

  • 39. Beta-2 microglobulin in ESRD: an in-depth review.
    Winchester JF; Salsberg JA; Levin NW
    Adv Ren Replace Ther; 2003 Oct; 10(4):279-309. PubMed ID: 14681859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Affinity binding of glycosaminoglycans with beta(2)-microglobulin.
    Ohashi K; Kisilevsky R; Yanagishita M
    Nephron; 2002 Feb; 90(2):158-68. PubMed ID: 11818700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.